Metraipolis › archive › dc_853478cb09ca

Differentiating Persistent Sepsis From Pembrolizumab-Induced Secondary Hemophagocytic Lymphohistiocytosis and Concurrent Immune-Mediated Nephritis: A… — Europe PMC PMID:42831226

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42831226
DOI
10.7759/cureus.115797
License (as archived)
solo-consultazione
Archived
2026-10-16T04:27:32.535Z
SHA-256 of the archived text
ef89ae247d7149df0789954c43717547b888c7bd7f66efc856eb3e0907fa858b
Stable URL of this page
https://metraipolis.com/documento/dc_853478cb09ca

How to cite

Differentiating Persistent Sepsis From Pembrolizumab-Induced Secondary Hemophagocytic Lymphohistiocytosis and Concurrent Immune-Mediated Nephritis: A… — Europe PMC PMID:42831226 — Europe PMC (en), https://europepmc.org/article/MED/42831226 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_853478cb09ca (Metraipolis archive dc_853478cb09ca, sha256 ef89ae247d7149df0789954c43717547b888c7bd7f66efc856eb3e0907fa858b)
BibTeX
@misc{dc853478cb09ca,
  title = {Differentiating Persistent Sepsis From Pembrolizumab-Induced Secondary Hemophagocytic Lymphohistiocytosis and Concurrent Immune-Mediated Nephritis: A… — Europe PMC PMID:42831226},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42831226},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_853478cb09ca; sha256 ef89ae247d7149df0789954c43717547b888c7bd7f66efc856eb3e0907fa858b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42831226. Agents can read the archived copy with the MCP tool read_document.